Gilbert Bensimon
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Stratifying IL-2 therapy in ALS: integrating biomarkers - Authors' reply.
Journal: Lancet (London, England)
Published: September 22, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: October 25, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis.
Journal: Annals of the New York Academy of Sciences
Published: May 21, 2024
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.
Journal: Journal of hepatology
Published: March 22, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Journal: Nature genetics
Published: February 01, 2022
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Journal: Nature genetics
Published: March 12, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2.
Journal: Brain communications
Published: January 05, 2021
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.
Journal: EBioMedicine
Published: March 31, 2020
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 14, 2018
Stage of prolonged survival in ALS - Author's reply.
Journal: The Lancet. Neurology
Published: May 23, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Journal: Molecular neurodegeneration
Published: May 16, 2018
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
Journal: The Lancet. Neurology
Published: October 27, 2017
Last Updated: 09/26/2026